Massachusetts-based startup Delix Therapeutics will work with the National Institute of Drug Abuse to test its patented version of ibogaine to see if it can ‘treat’ substance-use disorders. It has long been used by scientologists.
Massachusetts-based startup Delix Therapeutics will work with the National Institute of Drug Abuse to test its patented version of ibogaine to see if it can ‘treat’ substance-use disorders. It has long been used by scientologists.